Abstract
The goal of this open-label trial was to examine the efficacy and safety of a 12-week omega-3 fatty acids supplementation among children suffering with Autism Spectrum Disorders (ASD). A total of 41 children and adolescents aged 7–18 years (36 boys, 5 girls; mean age=11.66, s.d.=3.05) diagnosed with ASD participated in the study. At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale (P<0.01) and the Social and Attention Problems syndrome scales of the Child Behavior Checklist (P<0.05). Blood fatty acid levels were significantly correlated with changes in the core symptoms of ASD. Baseline levels of blood fatty acid levels were also predictive of response to the omega-3 treatment. Omega-3 fatty acids supplementation was well-tolerated and did not cause any serious side effects. Our findings lend some preliminary support for the use of omega-3 fatty acids supplementation in addressing ASD. Future randomized controlled trials of omega-3 fatty acids in ASD with blood fatty acid measurements with a larger sample and longer follow-up period is warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th edn. American Psychiatric Association: Washington DC, 2013.
Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC . Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 201–204.
Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M et al2006. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006; 67: 1954–1967.
Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M . Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 2005; 61: 551–553.
Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL . A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord 2011; 41: 545–554.
Meiri G, Bichovsky Y, Belmaker RH . Omega-3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol 2009; 19: 449–451.
Bent S, Bertoglio K, Hendren RL . Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disord 2009; 39: 1145–1154.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Association: Washington DC, 2000.
Wechsler D . Wechsler Intelligence Scale for Children (WISC-IV). 4th edn. Harcourt Assessment Inc: San Antonio, TX, USA, 2003.
Wechsler D . Wechsler Preschool and Primary Scale of Intelligence—Revised (WPPSI-R). The Psychological Corporation: San Antonio, TX, USA, 1989.
Constantino JN, Gruber CP . Social Responsiveness Scale. Western Psychological Services: Los Angeles, USA, 2005.
Achenbach TM, Rescorla LA . Research Center for Children, Youth, and Families Manual for the ASEBA School-Age Forms & Profiles. University of Vermont: Burlington, VT, USA, 2001.
Cohen J . Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Lawrence Erlbaum: Hillsdale, NJ, USA, 1988.
Yehuda S, Rabinovitz S, Mostofsky DI . Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 2006; 26: 98–102.
Simopoulos AP . The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002; 56: 365–379.
Acknowledgements
We thank Efamol for providing the omega-3 fatty acids supplementation and for partially sponsoring the study. We also thank Chee Yu Yan and Lim Ee Wen for their contribution to the study and the families of the persons who participated in the study.
DISCLAIMER
Efamol had no role in the design or conduct of the study, data collection, management, analysis and interpretation of the findings, and the preparation and approval of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ooi, Y., Weng, SJ., Jang, L. et al. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr 69, 969–971 (2015). https://doi.org/10.1038/ejcn.2015.28
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.28
This article is cited by
-
Serum Vitamin D, Folate and Fatty Acid Levels in Children with Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
Journal of Autism and Developmental Disorders (2022)
-
Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder
Journal of Autism and Developmental Disorders (2022)
-
Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review
Health and Quality of Life Outcomes (2020)
-
Equity, acceptability and feasibility of using polyunsaturated fatty acids in children and adolescents with autism spectrum disorder: a rapid systematic review
Health and Quality of Life Outcomes (2020)
-
A Randomised-Controlled Trial of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder in Children
Journal of Autism and Developmental Disorders (2019)